Publication Date:
2011-11-18
Description:
Abstract 1016 Transplantation of cells, tissues and organs is recognized by the World Health Organization (WHO) as a global task, no longer restricted to affluent countries. Still, there are few data relating to its use and trends on a global level and the macroeconomic factors associated with it. Data from 146,808 patients (pts) with hematopoietic stem cell transplantations (HSCT), 66,226 allogeneic (allo 45%), 80,582 autologous (auto 55%) from 1407 centers in 70 countries were used to describe the current status and to analyze trends over the period from 2006 to 2008. Transplant rates (TR, number of HSCT/10 million inhabitants) and their changes from 2006 to 2008 were assessed by main indication and donor type (leukemias (52,322 pat (36%), 47,674 allo, 4,648 auto); lymphoproliferative disorders (77,237 pts (53%), 9,846 allo, 67,391 auto); solid tumors (8,057 pat (5%), 399 allo, 7,658 auto) and non-malignant disorders and others (9,192 pts (6%), 8,307 allo, 885 auto) for each participating country and its corresponding WHO region America (42,470 pts (29%), 19,463 allo, 23,007 auto), Asia (including South-East Asia and Western Pacific) (25,931 pts (18%), 15,547 allo, 10,384 auto), Eastern-Mediterranean/Africa (3,986 pat (3%), 2,509 allo, 1,477 auto) and Europe (74,421 pat (51%), 28,707 allo, 45,714 auto). The associations of TR with Gross National Income per Capita (GNI/cap) and, for unrelated donor HSCT, with presence or absence of an unrelated donor registry were calculated by linear regression analyses. Proportions of donor type (p
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink